COMPOSITIONS COMPRISING A PSILOCYBIN DERIVATIVE AND A CANNABINOID
申请人:CaaMTech, LLC
公开号:US20190142851A1
公开(公告)日:2019-05-16
This disclosure pertains to new compositions and methods comprising a psilocybin derivative. In one embodiment, the compositions disclosed herein are used for a method of regulating a neurotransmitter receptor, e.g., a serotonin receptor. In one embodiment, the compositions disclosed herein comprise purified compounds, e.g., a purified psilocybin derivative, a purified cannabinoid, or purified terpene.
COMPOSITIONS COMPRISING A SEROTONERGIC TRYPTAMINE COMPOUND
申请人:CAAMTECH, INC.
公开号:US20210346346A1
公开(公告)日:2021-11-11
Disclosed herein are compositions comprising a serotonergic tryptamine compound, combinations thereof, and methods of using them for treating and preventing a variety of human conditions. In one embodiment, disclosed herein are new compositions and methods which comprise a therapeutically effective amount of a first purified psilocybin derivative and a therapeutically effective amount of a second compound. The second compound is selected from the group consisting of a second purified psilocybin derivative, a purified terpene, a serotonergic drug, an adrenergic drug, a dopaminergic drug, a purified erinacine, and a purified hericenone.
Erinacines A, B and C, strong stimulators of nerve growth factor (NGF)-synthesis, from the mycelia of Hericium erinaceum
The structures of novel diterpenoids, erinacines A, B, and C, isolated from the cultured mycelia of Hericiumerinaceum were determined by interpretation of the spectral data, and chemical and enzymatic reactions. These compounds showed potent stimulating activity of nervegrowthfactor (NGF)-synthesis.